论文部分内容阅读
目的:探究阿奇霉素联合布地奈德福莫特罗雾化吸入治疗支气管哮喘的治疗效果。方法:选择我院接受治疗的60例支气管哮喘患者,按治疗方式不同分为两组(n=30),观察组采用阿奇霉素联合布地奈德福莫特罗雾化吸入治疗,对照组采用布地奈德福莫特罗雾化吸入治疗,观察对比两组临床疗效。结果:观察组总有效率为90.0%,明显高于对照组的70.0%,P<0.05;观察组呼吸困难、咳嗽、肺部哮鸣音缓解消失的时间明显短于对照组,P<0.05。结论:布地奈德福莫特罗粉化吸入联合阿奇霉素治疗支气管哮喘相比单独用药,疗效确切,可短时间内控制临床症状,可作为支气管哮喘一种较佳的治疗方式。
Objective: To investigate the therapeutic effect of azithromycin and budesonide formoterol inhalation on bronchial asthma. Methods: 60 patients with bronchial asthma who were treated in our hospital were divided into two groups (n = 30) according to different treatment methods. The observation group was treated with azithromycin and budesonide formoterol inhalation. The control group was given budesonide Deformoterol inhalation therapy, observed and compared two groups of clinical curative effect. Results: The total effective rate in the observation group was 90.0%, which was significantly higher than that in the control group (70.0%, P <0.05). The observation group had shorter respiratory distress, cough and pulmonary wheeze relief than the control group (P <0.05). Conclusion: Forminib powder formoterol combined with azithromycin in bronchial asthma is more effective than bronchial asthma alone in treating bronchial asthma, which can be used as a better treatment for bronchial asthma.